GOLDMAN SACHS GROUP INC - EPIRUS BIOPHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

EPIRUS BIOPHARMACEUTICALS IN's ticker is EPRSQ and the CUSIP is 29428P107. A total of 41 filers reported holding EPIRUS BIOPHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of EPIRUS BIOPHARMACEUTICALS IN
ValueSharesWeighting
Q2 2016$8,000
-83.7%
16,776
+4.8%
0.00%–
Q4 2015$49,000
-5.8%
16,006
+37.2%
0.00%–
Q3 2015$52,000
-81.9%
11,664
-63.6%
0.00%–
Q1 2015$287,000
+378.3%
32,046
+202.4%
0.00%–
Q4 2014$60,000–10,596–0.00%–
 Download
Other shareholders
EPIRUS BIOPHARMACEUTICALS IN shareholders Q3 2015
NameSharesValueWeighting ↓
Apriem Advisors 500$00.00%
TPG Group Holdings (SBS) Advisors, Inc. 2,223,922$44,0000.00%
WEDBUSH SECURITIES INC 10,550$00.00%
View complete list of EPIRUS BIOPHARMACEUTICALS IN shareholders